RNAi Technology Global Market Report 2022: Featuring
Dublin, Dec. 01, 2022 (GLOBE NEWSWIRE) -- The "RNAi Technology Market, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis,...
Source: globenewswire.com
Page 5 - Rna Interference News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rna Interference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rna Interference Today - Breaking & Trending Today
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
Amgen posted positive Phase 2 data for olpasiran, further building the case for the drug's blockbuster potential in heart disease as it proceeds to a pivotal test. Arrowhead Pharmaceuticals, which originally developed olpasiran and licensed it to the big pharma company, is cashing in now by selling its royalty rights to the molecule.
Source: medcitynews.com
Alnylam Recognized by Science Magazine as Top Employer for Fourth Consecutive Year
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its second place ranking in Science Magazine’s 2022 Top Employer Survey .
Source: pressreleasepoint.com
U of T Engineering lab partners with Moderna to develop RNA-based tools to treat and prevent disease
Assistant Professor Omar F. Khan ( back row, second from left) and his lab team focus on diseases that are currently incurable and untreatable (photo by Safa Jinje)
Source: pressreleasepoint.com
Outlook on the Transfection Technologies Global Market to
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast...
Source: globenewswire.com